Literature DB >> 21402466

Perspectives on death and an afterlife in relation to quality of life, depression, and hopelessness in cancer patients without evidence of disease and advanced cancer patients.

Hanneke W M van Laarhoven1, Johannes Schilderman, Constans A H H V M Verhagen, Kris C Vissers, Judith Prins.   

Abstract

CONTEXT: It is unknown whether cancer patients with different life expectancies have different attitudes and emotions toward death and an afterlife. Also, it is unclear whether these attitudes and emotions toward death and afterlife influence patients' distress.
OBJECTIVES: To assess the relationship of attitudes and emotions towards death and an afterlife with quality of life, depression and hopelessness in cancer patients without evidence of disease and advanced cancer patients facing death.
METHODS: Ninety-one cancer patients without evidence of disease and 57 advanced cancer patients completed the Dutch Attitudes Toward Death and Afterlife Scale. Emotions toward death were measured using the Self-Confrontation Method. Quality of life was measured with the Satisfaction with Life Scale and the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life Questionnaire. Depression and hopelessness were measured with the Beck Depression Inventory for Primary Care and the Beck Hopelessness Scale.
RESULTS: Average scores on attitudes and emotions toward death and an afterlife were not significantly different between the two groups. However, in the no evidence of disease group, a negative association between negative emotions and social functioning was observed, which was not present in the advanced cancer group. In the advanced cancer group, associations were observed that were not present in the no evidence of disease group: positive associations between an explicitly religious attitude and global health status and between reincarnation belief and role and cognitive functioning, and a negative association between other-directed emotions and social functioning.
CONCLUSION: Patients without evidence of disease and advanced cancer patients do not differ in attitudes or emotions toward death, but the relationship between these attitudes and emotions and aspects of quality of life varies. When there is no evidence of disease, negative emotions play the most important role, whereas in the advanced cancer situation, attitudes toward death and an afterlife, which may provide meaning and value, become more prominent.
Copyright © 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21402466     DOI: 10.1016/j.jpainsymman.2010.08.015

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  6 in total

1.  Who Does Believe in life After Death? Brazilian Data from Clinical and Non-clinical Samples.

Authors:  Cristiane Schumann Silva Curcio; Alexander Moreira-Almeida
Journal:  J Relig Health       Date:  2019-08

2.  Attitude toward death in healthy people and patients with diabetes and cancer.

Authors:  Masoumeh Nozari; Yarali Dousti
Journal:  Iran J Cancer Prev       Date:  2013

3.  Psychometric properties of the Persian version of the Cancer attitude inventory.

Authors:  Maryam Khazaee-Pool; Alireza Shoghli; Tahereh Pashaei; Koen Ponnet
Journal:  BMC Public Health       Date:  2019-10-29       Impact factor: 3.295

4.  Late-life depressive symptoms, religiousness, and mood in the last week of life.

Authors:  Arjan W Braam; Marianne Klinkenberg; Henrike Galenkamp; Dorly J H Deeg
Journal:  Depress Res Treat       Date:  2012-07-15

5.  The facilitating role of chemotherapy in the palliative phase of cancer: qualitative interviews with advanced cancer patients.

Authors:  Hilde M Buiting; Wim Terpstra; Floriske Dalhuisen; Nicolette Gunnink-Boonstra; Gabe S Sonke; Govert den Hartogh
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

6.  Images of God and attitudes towards death in relation to spiritual wellbeing: an exploratory side study of the EORTC QLQ-SWB32 validation study in palliative cancer patients.

Authors:  Renske Kruizinga; Michael Scherer-Rath; Johannes B A M Schilderman; Mariëtte Weterman; Teresa Young; Hanneke W M van Laarhoven
Journal:  BMC Palliat Care       Date:  2017-12-08       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.